The PROTECTION Trial – A Randomized Trial of Intravenous Amino Acids for Kidney Protection
REBEL EM
AUGUST 12, 2024
What They Did: Double-blind, randomized, placebo controlled trial that ran from October 2019 through January 2024 Multinational study conducted at 22 centers in three European countries 3512 patients were enrolled and before surgery eligible patients were randomly assigned to one of the following two groups Amino Acid Group: 10% Isopuramin at a dose (..)
Let's personalize your content